When was Allevi founded?

Allevi was founded in 2014 and raised its 1st funding round within a year of its incorporation.

Where is Allevi located?

Allevi is headquartered in Philadelphia, United States.

Who is the current CEO of Allevi?

Ricky Solorzano and Frank McCaney s of Allevi.

How many employees does Allevi have?

As of Jul 01, 2024, the latest employee count at Allevi is 16.

Is Allevi a funded company?

Allevi is a funded company, having raised a total of $2.33M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 22, 2014.

When was the latest funding round of Allevi?

Allevi's latest funding was a $***** Seed round on Oct 30, 2019, with participation from 0 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $909M in funding in 2026 to date.

Where does Allevi rank among its competitors?

Allevi ranks 2nd amongst 89 active competitors, of which 21 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was CurifyLabs, which secured $14M in Jul, 2026.

Who are the top competitors of Allevi?

Allevi's top competitors include Aspect Biosystems, Xlife sciences and CurifyLabs. Among them, CurifyLabs secured the most recent funding round in July, 2026.

Allevi - 2026 Company Profile, Team, Funding & Competitors

Allevi is an acquired company based in Philadelphia (United States), founded in 2014 by Ricky Solorzano. It operates as a 3D bioprinting solutions: bioprinters, bioinks, and software for tissue engineering. Allevi has raised $2.33M in funding from 500 Global and Ben Franklin Technology Partners. The company has 89 active competitors, including 21 funded and 12 that have exited. Its top competitors include companies like Aspect Biosystems, Xlife sciences and CurifyLabs.

Company Details

3D bioprinting solutions: bioprinters, bioinks, and software for tissue engineering. They provide simplified bioprinting with versatile desktop 3D bioprinters, diverse bioinks, and user-friendly software. Their technology empowers researchers to design and engineer 3D tissues for applications like regenerative medicine, drug discovery, and disease modeling. They offer tools for extrusion bioprinting, precision printing, and creating complex geometries. Their products include bioprinters, bioinks for various tissues (liver, heart, bone, etc.), and essential reagents. They support the scientific community with resources like bioprinting protocols, blogs, webinars, and application notes. They also have an online shop with products like nozzles, alginate, photoinitiators, and calcium chloride. They offer login access for software, services, and support. They are focused on advancing bioprinting and regenerative medicine.

Website: www.allevi3d.com/
Social

Key Metrics

Founded Year

2014

Location

Philadelphia, United States

Stage

Acquired

Total Funding

$2.33M in 4 rounds

Latest Funding Round

Seed, Oct 30, 2019, $*****

Investors

500 Global & 16 more

Ranked

2^nd among 89 active competitors

Employee Count

16 as on Jul 01, 2024

Similar Companies

Aspect Biosystems & 109 more

Exit Details

Acquired by 3D Systems (May 06, 2021)

View Allevi's full profile

Allevi got acquired by 3D Systems on May 06, 2021.

Click here to take a look at Allevi's acquisition in detail

Allevi has raised a total funding of $2.33M over 4 rounds. Its first funding round was on Oct 22, 2014. Allevi has 17 institutional investors.

Here is the list of recent funding rounds of Allevi:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 30, 2019	2623640	Seed	2523236	2686457	1175001	7850798
Nov 10, 2017	4912709	Seed	8651846	8319138	8908923	9322943
Aug 11, 2015	1903517	Seed	1412851	7896388	500 Global & 1 more	Dreamit

Access funding benchmarks and valuations. Sign up today!

View details of Allevi's funding rounds and investors

The founders of Allevi is Ricky Solorzano. Ricky Solorzano is the CEO of Allevi.

Here are the details of Allevi's key team members:

Ricky Solorzano: Co-Founder & CEO of Allevi.
Frank McCaney: Former Co-Founder of Allevi.

View details of Allevi's Founder profiles and Board Members

Allevi's employee count trend

Allevi has 16 employees as of Jul 24. Here is Allevi's employee count trend over the years:

Uncover Allevi's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Allevi include Aspect Biosystems, Xlife sciences and CurifyLabs. Here is the list of Top 10 competitors of Allevi, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Aspect Biosystems 2013, Vancouver (Canada), Series B	Developer of bioprinting technology and tissue therapeutics for regenerative medicine	$139M	Pangaea Ventures, Radical Ventures & 21 others	68/100
2nd	Allevi 2014, Philadelphia (United States), Acquired	3D bioprinting solutions: bioprinters, bioinks, and software for tissue engineering	$2.33M	Sand Hill Venture Capital, FundersClub & 15 others	59/100
3rd	Xlife sciences 2013, Zurich (Switzerland), Public	Developer of drugs for multiple diseases	$62.8M	-	58/100
4th	CurifyLabs 2021, Helsinki (Finland), Series A	Provider of digital 3D printing solutions for personalized medicine	$33.8M	Healthcap, Springvest & 8 others	57/100
5th	BICO 2016, Boston (United States), Public	Provider of technologies, products, and services for life sciences research purposes	-	Fore C Investment, Europa & 1 others	56/100
6th	VoxCell BioInnovation 2020, Victoria (Canada), Series A	Manufacturer of 3D bioprinters	$4.54M	E-Fund, Telus & 4 others	54/100
7th	ROKIT Healthcare 2012, Seoul (South Korea), Public	Provider of 4D bio-printer solutions for tissue regenerative	$30M	DRADS Capital, Korean Development Bank & 16 others	54/100
8th	FabRx 2014, London (United Kingdom), Unfunded	3D printed drugs	-	-	50/100
9th	CTIBiotech 2009, Lyon (France), Funding Raised	Develops 3D human tissue models	-	Bpifrance, Government of France	46/100
10th	Cyfuse 2010, Bunkyo (Japan), Public	Developer of 3D tissue engineering technology	$16.6M	JAFCO Group, UTEC & 12 others	45/100